Hypokalemia: All insulins, including NovoLog , can cause a shift in potassium from the extracellular to intracellular space, possibly leading to hypokalemia
Smaller infarct areas were observed in hearts treated with GLP-1(2836) or GLP-1 (positive controls) as compared with hearts treated with saline or scrambled(2836) (Scram) (negative controls)
Dosage Forms and Strengths SOLIQUA 100/33 is a clear, colorless to almost colorless solution available as: Injection: 100 units of insulin glargine and 33 mcg of lixisenatide per mL in a 3 mL prefilled, disposable, single-patient-use SoloStar pen
Wu J, Li Z, Yang Z, Guo L, Zhang Y, Deng H, et al
Use our peptide stack calculator to plan your combination protocol and calculate total costs